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Abstract
It is currently known that pluripotent stem cells can be committed in vitro to the cardiac line-
age by the modulation of specific signaling pathways, but it is also well known that, despite
the significant increase in cardiomyocyte yield provided by the currently available condi-
tioned media, the resulting cardiogenic commitment remains a highly variable process.
Previous studies provided evidence that radio electric fields asymmetrically conveyed
through the Radio Electric Asymmetric Conveyer (REAC) technology are able to commit
R1 embryonic stem cells and human adipose derived stem cells toward a cardiac pheno-
type. The present study aimed at investigating whether the effect of physical stimulation by
REAC in combination with specific chemical inductors enhance the cardiogenic potential in
human induced pluripotent stem cells (iPSCs). The appearance of a cardiac-like pheno-
type in iPSCs cultured in the presence of a cardiogenic medium, based upon BMP4 and a
WNT-inhibitor, was consistently increased by REAC treatment used only during the early
fate differentiation for the first 72 hours. REAC-exposed iPSCs exhibited an upregulation
in the expression of specific cardiogenic transcripts and morphologically in the number of
beating clusters, as compared to cells cultured in the cardiogenic medium alone. Our
results indicate that physical modulation of cellular dynamics provided by the REAC offers
an affordable strategy to mimic iPSC cardiac-like fates in the presence of a cardiogenic
milieu.
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Introduction
Stem cell-based therapy currently represents a promising approach for regenerative medi-
cine, although the translation of the in vitro studies into clinical applications is in part com-
plicated by the difficulty in obtaining a high yield of differentiation within specific and
homogenous stem cell-derived lineages that can provide their safety. There is increasing
evidence that defined stem cell commitment can be promoted not only by chemical agents[1,
2] but can result from exposure to physical energies. In this regard, we have shown that
exposure to Radio Electric Asymmetric Conveyer (REAC) technology with specific treat-
ment protocol, can promote multi-lineage commitment, like cardiogenesis, neurogenesis
and skeletal myogenesis, in mouse embryonic stem (ES) cells[3] and in human adipose-
derived mesenchymal stem cells (ADhMSCs)[4, 5], also modulating the expression of
stemness-related genes and the commitment to cardiac-, neural- and skeletal muscle-like
fates in human fibroblasts[6]. Moreover, previous studies have shown that REAC technology
can also influence other processes[7], activating both telomerase-dependent and indepen-
dent pathways to counteract and even reverse stem cell senescence in vitro[8–10]. These
responses to REAC exposure involved a major role of intracellular hyaluronic acid pattern-
ing and the establishment of intracellular networks acting on the modulation of cell polarity
[11].
The discovery of induced pluripotent stem cells (iPSCs)[12] has notably transformed previ-
ously defined stem cell-based therapeutic approaches[13] showing new applications for regen-
erative medicine[14], drug discoveries and developmental studies[15]. Many investigators
have focused their efforts on developing strategies to efficiently and reliably direct stem cell dif-
ferentiation towards the cardiovascular lineage [16], holding hopes for future clinical applica-
tions [17]. Pluripotent stem cells can be committed in vitro to the cardiac phenotype by the
modulation of specific signaling pathways[18], afforded by naturally occurring molecules[19].
Despite the significant increase in cardiomyocyte yield provided by the currently available
conditioned media, the resulting cardiogenic commitment[20] remains a variable and prob-
lematic process. The present study aims at investigating whether REAC technology may be
used in cooperation with specific cardiogenic inductors to turn iPSC cardiogenesis into a
high-throughput and reproducible differentiating outcome. Here, REAC exposure has been
applied to enhance cardiogenesis in iPSCs obtained from human exfoliated epithelial cells
from urine (hUiPSCs) by the aid of non-integrating technologies [21]. Since spontaneous car-
diogenesis is a low-yield, variable process even in embryonic stem cells, the current observa-
tion that REAC technology with specific treatment protocols can promote the achievement of
a cardiac phenotype in hUiPSCs unravels novelty within the methods actually in use to com-
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Description of Radio Electric Asymmetric Conveyer (REAC) technology
Radio Electric Asymmetric Conveyer Technology for therapeutic use (REAC) is a technology
for bio and modulation. The REAC technology generates a radio electric emission of very low
intensity. The radio electric emission interacts with all the structures that contain electrical
charges, such as the human body, and induces currents in them. These currents vary according
to the molecular characteristics of the tissues. The peculiarity of REAC technology is not the
radio electric emission itself, but the particular physic link between the device and the patient’s
body. The “Asymmetric Conveyer Probe” (ACP) represents this link. This is the innovation of
REAC technology. This scheme has been developed for a specific purpose: to create an asym-
metric circuit for better interact with the asymmetric mechanism underlying the cell polarity
[22], in order to optimize its functions. In fact, REAC technology is able to modulate the cur-
rent flows existing both at cellular and body level, when these are altered. Another peculiarity
of REAC Technology is the low power level used in radio frequency emission. This is necessary
to induce current flows of intensity comparable with those of cell polarity. Higher power levels
would disturb the adjustment mechanisms of cell polarity. The REAC technology is indepen-
dent of the radio frequency emission used. REAC devices use only two frequencies (2.4 and 5.8
GHz). These two frequencies were chosen for two reasons. First of all, these are the most
widely used and permitted at the international level. Secondly, based on our clinical and scien-
tific experience, the 2.4 GHz frequency was chosen to better interact with tissues and cell cul-
tures [3–7, 10, 23–27], while the 5.8 GHz frequency was chosen to better interact with the
nervous system.
The electromagnetic quantities have been measured immerging the REAC ACP into the
culture medium, inside a CO2 incubator, using the spectrum analyzer Tektronix model 2754p
and orienting the receiving antenna for maximum signal. The distance between the device and
the culture medium was approximately 35 cm. Radiated power was about 2 mW, electric field
E = 0.4 V/m, magnetic field 1 mA/m, specific absorption rate (SAR) 0.128 μW/g; determinate
σ = 1 A/V.m and ρ = 1000K g/m3 the density of radio electric current flowing in the culture
medium during a single REAC pulse was J = 30 μA/cm2. The REAC treatment protocol used
in this study was tissue optimization (TO) regenerative treatments (RGN). The REAC model
device used in this study was B.E.N.E (ASMED, Florence, Italy).
hUiPSC culture
The hUiPSCs line was developed from urine-derived cells as previously described [28]. Cells
were routinely grown on Matrigel Matrix (Invitrogen) in mTeSR_1 medium (STEMCELL
Technologies) at 37˚C degree in an incubator with 5% CO2 and 3% O2. Cells were subcultured
using STEMPRO ACCUTASE (Life Technologies) and ROCK-Inhibitor Y-27632 (Enzo Life
Sciences).
Cardiomyocyte differentiation
Undifferentiated hUiPSCs were digested into smaller clusters using ACCUTASE and seeded
onto Matrigel-coated plates at 3 � 105 cells/10 cm2 in mTeSR1 medium until they reached
80%–90% confluence. Thereafter, the cells were digested into single-cell suspensions and
seeded into ultralow-attachment six-well plates (Corning) and cardiac differentiation was
induced as described elsewhere[29]. Briefly, cells were kept for 24 hours in mTeSR1 medium
with Matrigel (40 mg/mL), BMP4 (1 ng/mL; Invitrogen) and Rho kinase inhibitor (ROCK)
(10 μM; R&D) under a hypoxic condition with 3% O2. Then, the first group of cells was
washed and replaced in cardiogenic medium (Medium C -REAC), containing: StemPro34
SFM (Invitrogen) with ascorbic acid (AA, 50 mg/mL; Sigma), 2mM Gluta-MAX-1
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(Invitrogen), BMP4 (10 ng/mL), and human recombinant activin-A (10 ng/mL; Invitrogen).
The second group of cells (Medium C+REAC) was replaced in the presence of the cardiogenic
medium and additionally exposed to REAC for 72 hours. On day 4 both groups of cells were
incubated with IWR-1, a Wnt inhibitor (5 mM; Enzo Life Sciences). On day 8, all cells were
transferred to a normoxic environment and maintained in cardiogenic medium until the end
of experiment (day 14). Cardiac mesodermal cells organized in functional contracting clusters
were detected as early as day 8.
RNA extraction, cDNA synthesis, and gene expression analysis by real-time
PCR
Total RNA was isolated using Trizol reagent according to the manufacturer’s instructions
(Sigma). Total RNA was dissolved in RNAase-free water and quantitated using a Nanodrop.
A twenty-μl reaction volume containing 1 μg total RNA was reverse transcribed using Hi
Capacity cDNA reverse transcription kit (Applied Biosystem) with oligo (dT) primers. qPCR
reaction was performed using Rotorgene machine (Qiagen) with EvaGreen mix (Biolab).
After an initial denaturation step at 95˚C for 15 min, temperature cycling was initiated.
Each cycle consisted of 95˚C for 15 sec., 53–59˚C for 30 s, and 72 ˚C for 15 sec., the fluores-
cence being read at the end of this step. All primers used in this work were from Invitrogen
and are listed in Table 1.
Immunostaining
hUiPSCs (Embryo bodies clusters), cultured in the cardiogenic medium (Medium C) with or
without REAC exposure for the first 72 hours, were digested at day 14 by collagenase 1 (Invi-
trogen) for 1 hour at 37˚C, and the resulting suspension was cultured at low density to visual-
ize individual cells. The cultures were fixed with absolute methanol for 30 min and 1 hour at
-80˚C. Cells were then exposed to antibodies against α-sarcomeric actinin (Mouse, Sigma,
Clone EA-53), Cardiac troponin T (Mouse, Thermo scientific, 1F11) GATA4 (Mouse, Santa
Cruz, sc-25310), MEF2C (Rabbit, Thermo scientific, PA5-28247) or to TBX5 (Rabbit, Thermo
scientific, PA5-29845) for 1 hour at 37˚C, followed by staining with the respective secondary
antibodies anti mouse Alexa fluor 594 or anti rabbit Alexa fluor 498 at 37˚C for 1 h. All micros-
copy was performed with a Leica confocal microscope (LEICA TCSSP5). DNA was visualized
with DAPI (1 μg/ml).
Table 1. Primers used in this work.









PCR products were confirmed by melting curve analysis and electrophoresis. All measurements were done as technical quadruplicate of biological triplicates. Biological
replicates were obtained from independent differentiation setup. Relative expression was determined using “2^ΔΔCt method” with glyceraldehyde 3-phospate
dehydrogenase (GAPDH) as normalizing expression levels.
https://doi.org/10.1371/journal.pone.0211188.t001
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Counting of beating cells
Cells seeded in ultralow-attachment six-well plates (Corning) aggregated in EBs clusters were
examined under an inverted live microscope (Leika) at 37˚C at different time points. In each
well (9.5 cm2) total EBs were counted at a field with an area of 1 mm2. Ten to fifteen fields in
each well were randomly chosen and counted. The percentage of contractile EBs was deter-
mined as the number of EBs that showed spontaneous contraction divided by the total number
of EBs plated.
Immunoblotting
Cells were cultured in cardiogenic medium (MEDIUM C) in the presence or absence of REAC
for 72 hours. Total cell lysates from hUiPSCs committed with cardiogenic medium with or
without REAC were electrophoresed on 10% Novex Tris-glycine polyacrylamide gels (Invitro-
gen) in MOPS sodium dodecyl sulfate running buffer using an XCell SureLock Mini-Cell
(Invitrogen) according to the instructions provided by the manufacturer. After protein trans-
fer to polyvinylidenedifluoride membranes (Invitrogen), membranes were saturated and
washed, immunoreaction was carried out for one hour at room temperature in the presence of
the primary antibody, antisera against Cardiac troponin T (Mouse, Thermo scientific, 1F11),
GAPDH (Mouse, Thermo scientific) diluted to 1:1000. After additional washing, membranes
were incubated with antirabbit α-Sarcomeric (Rabbit, Santa Cruz). Targeted protein expres-
sion was assessed using a chemiluminescence detection system (ECL Western blotting
detection reagents were from Amersham Biosciences Corporation, Piscataway, NJ, USA).
Densitometric analysis was performed on the images using ImageJ software Fiji extension. We




Statistical analysis was performed using GraphPad Prism 7.03 software; this software gives a
corrected p-value for multiple comparisons by comparing means regardless different time
point and the treatment with or without REAC for the different biological replicate. For this
study, the non-parametric ANOVA two-way and in conjunction Sidak’s multiple comparison
test were applied. The tests and results with p< 0.05 (95% confidence interval) were consid-
ered statistically significant considering values of interaction, Row factor and column factor
below 0.05 as limit of significance, with The ANOVA two-way was used to evaluate the distri-
butions and homogeneity variance in the groups among undifferentiated hUiPSCs and cells
committed to cardiogenesis in the absence (Medium C alone) or presence of REAC.
Results
Evaluation of UIPSCs features in culture
iPS cells culture is apparently simple and not so different from the culture of other cell types.
Yet, it has the peculiarity of the instability. In fact, although cultured with rigorous and repro-
ducible methods, these cells very often tend to autonomously differentiate. That means that if
used for differentiation in experiments, iPS cells could result in consistently different outcomes
of differentiation. On this basis, for each experiment the morphology and probable self-differ-
entiation (Fig 1) was evaluated throughout the 14 days of culturing.
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We have also analyzed the expression of the pluripotency genes at day 0 before the commit-
ment and during the 14 days of differentiation in culture, to detect changing in the molecular
differentiation program through the downregulation of OCT, SOX3 / 4, NANOG and cMyc
(Fig 2).
REAC-RGN treatment protocol enhances the expression of the cardiogenic
and cardiac specific genes
REAC-RGN exposure of hUiPSCs in the presence of Medium C remarkably enhanced the
transcription of the early cardiogenic markers Nkx2.5 and GATA4, encoding a homeodomain
and a zinc finger essential in early cardiogenesis, as compared to expression levels achieved in
the presence of the cardiogenic medium alone (Fig 3), that seem actively regulated in the pres-
ence of cardiogenic medium containing BMP4 and the WNT-1 inhibitor compared to starting
point IPS cells at day 7 but not at day 3.
Gene expression levels of both T-Box protein 5 (TBX5) and MADS box transcription
enhancer factor 2 (MEF2), pivotal proteins during cardiogenic commitment, were also dra-
matically increased in hUiPSCs that had been cultured in Medium C in the presence of the
physical modulation by REAC at 14 days.
The use of physical energies in combination with the cardioinductive compounds consis-
tently enhanced the transcription of genes underlying a terminal cardiac differentiation,
including ACTN2, encoding an actin-binding protein, alpha-myosin heavy chain (MHC) and
the Troponin complex (cTnT), encoding two major cardiac sarcomeric proteins. These effects
Fig 1. Representative morphologycal evaluation of hUiPSCs over the time in supplemented defined medium and REAC. hUiPSC at day 0 and during the
differentiation, culturing in 3D condition in cardiogenic conditioned medium in the absence (Medium C-REAC) or presence of REAC (Medium C+REAC). The
yellow circles in the pictures represent the beating cluster zones. The yellow scale bars are 200 μm.
https://doi.org/10.1371/journal.pone.0211188.g001
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were detected as early as 72 h and peaked after 14 days, underling a strong and mature differ-
entiation on the molecular activation way (Fig 4).
REAC-RGN treatment protocol drives the expression of cardiac specific
marker proteins
However, to prove the effectiveness of the synergic action on the UiPSCs by REAC-RGN and
BMP4, WNT-1 inhibitor even on the protein level, confocal microscopy analysis was per-
formed in order to validate molecular gene expression observations. Interestingly, REAC-RGN
exposure resulted in a consistent increase in the yield of cells positively stained for the cardiac
specific marker proteins cTnT, accord with gene expression activation. As well, MEF2C, α-sar-
comeric and TBX5, as compared to cells that had been cultured with Medium C alone (Fig 5)
confirm again transcriptional observations.
As expected for terminally differentiated myocardial cells, the expression of GATA4, an
early cardiogenic transcription factor, was only faintly detectable in REAC-RGN exposed cells
(Fig 5). These results were further inferred by western blot analysis of the specific cardiac pro-
tein α-sarcomeric actinin and cTNT (Fig 6).
Fig 2. Effect of REAC treatment on the expression of pluripotency genes in hUiPSCs supplemented with defined medium. Cells cultured in cardiogenic
conditioned medium (Medium C) were exposed for 72 h, in the absence (grey bars) or presence (red bars) of REAC and then cultured in the presence of medium C
alone until day 14th. The amount of OCT4(A), SOX3/4 (B), NANOG (C) and cMyc (D) mRNA from untreated (grey bars) or REAC-treated (red bars) cells was
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and was plotted as fold of change relative to the mRNA expression in hUiPSCs at day 0. Data
shown mean±S.D; n = 4 (P<0.05 ��), (P<0.001� ��).
https://doi.org/10.1371/journal.pone.0211188.g002
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REAC-RGN treatment maximizes the yield of spontaneously beating
cardiomyocytes
The achievement of a cardiac phenotype was remarkably confirmed by the observation
that REAC-RGN exposure of Medium C-supplemented cells consistently increased the num-
ber of beating clusters of hUiPSCs-derived cardiomyocytes. In particular, the exposure to
REAC-RGN treatment anticipated the appearance of beating clusters at day 8th, while a con-
sistent number of beating clusters could be observed at day 14th in Medium C- supplemented
hUiPSCs (Fig 7).
At day 10th, more than 100 beating clusters/well were consistently observed, with a further
progressive increase at later observational times. On the contrary, as shown in Fig 5, a far lesser
number of beating clusters was detected from cells that had been cultured in the presence of
Medium C alone.
Discussion
In the field of regenerative medicine iPSCs hold a high promise for future development, owing
to its easy and wide-ranging opportunities for harvesting, and for the possibility of being gen-
erated even by non-integrating technologies[21], however one of the main issues is to find a
way to improve their differentiation in order to create a stable population for further
applications.
We previously demonstrated that the use of physical energies by REAC-RGN in R1 mouse
embryonic stem cells during the early stage of cardiac commitment was able to modulate the
expression of GATA4 and NKX-2.5 genes, two pivotal transcription factors orchestrating
Fig 3. Effect of REAC treatment on the expression of cardiogenic transcripts in hUiPSCs supplemented with defined medium. Cells cultured
in cardiogenic conditioned medium (Medium C) were exposed for 72 h, in the absence (grey bars) or presence (red bars) of REAC and then
cultured in the presence of medium C alone until day 14th. The amount of GATA4 (A), Nkx-2.5 (B), Tbx5 (C) and Mef2C (D) mRNA from
untreated (grey bars) or REAC-treated (red bars) cells was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and was plotted as
fold of change relative to the mRNA expression in hUiPSCs at day 0. Data shown mean±S.D; n = 4 (P<0.05 ��), (P<0.001� ��).
https://doi.org/10.1371/journal.pone.0211188.g003
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cardiogenesis, thus promoting the appearance of a cardiac phenotype. Within this context,
other authors also showed that electromagnetic fields, another kind of physical stimulus, com-
mitted embryonic stem cells to cardiogenesis by modulating ROS production, and intracellular
ion concentrations[30–32] [33].
In the present paper, we aimed to figure out the behavior of hUiPSs exposed to REAC-RGN
during the cardiogenic differentiation in the presence of BMP4 and WNT-1 inhibitor. Our
results showed that the use of physical stimulation by REAC in combination with cardioinduc-
tive medium was able to increase the modulation of transcription factors genes GATA4, NKX-
2.5, TBX5, mainly involved in cardiac fate in the early three days of differentiation. This trend
was maintained during time, acting on the mature differentiation in beating cardiomyocytes
after eight days in culture under the differentiating stimuli. These observations were further
inferred by the study of both gene expression and protein levels (immunohistochemistry) of
cTnT, MEF2C, α-sarcomeric, cardiac specific proteins expressed only in mature myocytes.
Modulation of stem cell fate is an extremely fascinating mechanism finely controlled by an
uncountable number of variabilities still not well defined. However, here we demonstrate that
the use of REAC conveyed radioelectric fields can interact with this fate, and hypothesize that
cardiogenesis can be turned into a high-throughput process by a main mechanism elicited by
physical energies in combination with specific compounds. To this end, we cannot exclude the
involvement of ROS production and the activation of a WNT non-canonical pathway. Indeed,
it has been previously demonstrated that redox-based mechanisms can have a central role in
cardiogenic differentiation[34] and in beating cluster formation. Recent studies indicated the
Fig 4. Effect of REAC treatment on the expression of early cardiac-specific marker genes in hUiPSCs supplemented with defined medium. Cells
cultured in cardiogenic conditioned medium (Medium C) were exposed for 72 hours, in the absence (grey bars) or presence (red bars) of REAC, and then
cultured in the presence of medium C alone until day 14. The amount of ACTN2 (A), αMHC (B), and cTnT (C) mRNA from untreated (grey bars) or REAC-
treated (red bars) cells was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and was plotted as fold of change relative to the mRNA
expression of hUiPSCs at day 0. Data shown mean±S.D; n = 4 (P<0.05 ��), (P<0.001� ��).
https://doi.org/10.1371/journal.pone.0211188.g004
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potential involvement of the transmembrane enzyme NADPH oxidases (Noxs), in particular
Nox4, which catalyzes the reduction of molecular oxygen to superoxide anion, in this process
[35, 36]. Within this context, we have previously demonstrated the direct involvement of
NADPH oxidase, and ROS signaling during the direct cell reprogramming induced by REAC
[6]. The use of physical energies, in combination with specific growth factors like BMP4 and
the use of WNT-1 inhibitor apparently increase the cardiogenic commitment. It has been
Fig 5. Immunohistochemical analysis of cardiac specific proteins. hUiPSCs exposed for 72 hours to conditioned medium in the absence (Medium
C-REAC) or presence of REAC (Medium C+REAC) were disaggregated after 14 days from time 0 (undifferentiated hUiPSCs) seeded in chamber slide and
processed for immunostaining using specific antibodies directed against: Troponin complex (cTnT), MADS box transcription enhancer factor 2 (MEF2C),
GATA binding protein 4 (GATA4), α-sarcomeric actinin (A-Sarc) and T-Box protein 5 (TBX5). Confocal microscopy analysis was performed with Leica
confocal microscope (LEICA TCSSP5). Nuclei were labeled with DAPI (blue). The yellow scale bars are 100 μm.
https://doi.org/10.1371/journal.pone.0211188.g005
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largely described, that non-canonical or β-catenin-independent WNT pathway orchestrates
planar cell polarity by cytoskeleton reorganization[37]. We have previously shown that the
molecular effect elicited by REAC on adipose derived stem cells involved the synthesis of hyal-
uronic acid, which controls cell growth and polarity, and thus stem cell capability to acquire a
specific phenotype[11].
Fig 6. Effect of REAC treatment on the expression of cardiogenic markers in hUiPSCs after 14 days. Total lysates were isolated from hUiPSCs
committed by Cardiogenic medium (Medium C) in the absence or presence of REAC treatment for 72 hours. Samples were analyzed by Western blot,
using antisera against α-Sarcomeric actinin (α-Sarc), cardiac troponin T (cTNT) and GAPDH (A). The sizes of the bands were determined using
prestained marker proteins. The data presented are representative of five separate experiments. Two different membranes were incubated with anti-
mouse (cTNT, GAPDH) or anti-rabbit (α-Sarc), densitometry analysis for α-Sarc (B) and cTnT (C) were performed with ImageJ.
https://doi.org/10.1371/journal.pone.0211188.g006
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Here, by the chemical block of WNT-1 we induced cardiogenesis probably promoting the
non-canonical activation pathway. From our results and previous findings we can postulate
that the electromagnetic and radio electric field energies emitted by REAC during the first
three days of cardiogenic commitment may recapitulate the physiological behavior of ES cells
during cardiogenesis through the WNT-non canonical pathway modulation[38].
The discovery of iPSCs has surely opened new ways and perspectives in the field of regener-
ative medicine, in particular in personalized medicine. From the pharmaceutical point of view,
the discovery of iPSCs has allowed the creation of specific cellular models addressed to the
understanding of specific diseases. However, finding a protocol and a method that can allow a
high and reproducible yield is still an open issue. Cell differentiation is one of the crucial points
still under study. The focus is trying to create a more physiological environment for cells, both
at the molecular, and possibly physical level. These stimuli should have the capability of mim-
icking the physiological environment by increasing the activation of specific pathways
involved in phenotypic maturation of cells and tissues.
The hostile inflammatory environment typical of post-infarction necrotic tissue together
with the lack of oxygen in the ischemic area may limit the survival and proliferation of endoge-
nous progenitor cells, possibly promoting scar formation and even switching endogenous
stem cells to a fate of fibrosis[39]. Hence, a novel strategy could be boosting endogenous mech-
anisms of regeneration by the identification of a specific protocol, leading to improved cellular
resistance to oxidative stress and to increase proliferation and commitment of progenitor pop-
ulations to cardiomyocyte and other cardiopoietic lineages, to repair the injured tissue[40].
We have previously shown that REAC is able to modulate stem cell pluripotency acting as a
hormetic factor, able to strengthen stem cell behavior in inflammatory conditions. Combining
Fig 7. Analysis of the beating clusters. The Figure shows the analysis of the yield of total spontaneously beating clusters obtained from hUiPSCs aggregated as EBs
grown in cardiogenic conditioned medium in the absence (continuous grey line) or presence of REAC (continuous red line). Also shown is the percentage of
beating clusters, assessed as the number of EBs that showed spontaneous contraction divided by the total number of EBs plated in cardiogenic conditioned
medium in the absence (discontinuous grey line) or presence of REAC (discontinuous red line), and then assayed at the indicated time periods for the appearance
of a contractile activity (mean ± SE; n = 4).
https://doi.org/10.1371/journal.pone.0211188.g007
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molecules that can induce cardiogenesis, and at the same time creating a favorable milieu in
which the same cells can acquire a specific phenotype despite the hostile environment will rep-
resent in the next future a great breakthrough to clinical studies.
Our finding that REAC technology can unfold a gene and protein expression program pro-
moting an increase in the yield of spontaneous beating cardiac-like cells prompts the chance to
circumvent the extremely low-yield of spontaneous cardiogenesis, so far, a considerable draw-
back in stem cell based regenerative medicine, drug discovery and developmental biology
studies.
Supporting information
S1 File. Approval of the study by the IRB of the Centre for developmental biology and
reprogramming (CEDEBIOR) of University of Sassari.
(PDF)
Author Contributions
Conceptualization: Valentina Basoli, Salvatore Rinaldi, Vania Fontani, Regina Grillari, Mar-
gherita Maioli.
Investigation: Valentina Basoli, Sara Santaniello, Gianfranco Pigliaru, Matthias Wieser, Agata
Strajeriu, Alessandro Castagna.
Supervision: Heinz Redl, Carlo Ventura.
Visualization: Valentina Basoli, Sara Santaniello, Gianfranco Pigliaru, Matthias Wieser, Agata
Strajeriu, Alessandro Castagna.
Writing – original draft: Valentina Basoli, Salvatore Rinaldi, Vania Fontani, Regina Grillari,
Margherita Maioli.
Writing – review & editing: Valentina Basoli, Sara Santaniello, Salvatore Rinaldi, Vania Fon-
tani, Gianfranco Pigliaru, Matthias Wieser, Agata Strajeriu, Alessandro Castagna, Heinz
Redl, Carlo Ventura, Regina Grillari, Margherita Maioli.
References
1. Maioli M, Basoli V, Carta P, Fabbri D, Dettori MA, Cruciani S, et al. Synthesis of magnolol and honokiol
derivatives and their effect against hepatocarcinoma cells. PloS one. 2018; 13(2):e0192178. https://doi.
org/10.1371/journal.pone.0192178 PMID: 29415009
2. Basoli V, Santaniello S, Cruciani S, Ginesu GC, Cossu ML, Delitala AP, et al. Melatonin and vitamin D
interfere with the adipogenic fate of adipose-derived stem cells. International journal of molecular sci-
ences. 2017; 18(5):981.
3. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Gualini S, et al. Radiofrequency energy loop
primes cardiac, neuronal, and skeletal muscle differentiation in mouse embryonic stem cells: a new tool
for improving tissue regeneration. Cell Transplant. 2012; 21(6):1225–33. Epub 2011/10/07. https://doi.
org/10.3727/096368911X600966 PMID: 21975035.
4. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, et al. Radioelectric asymmetric
conveyed fields and human adipose-derived stem cells obtained with a nonenzymatic method and
device: a novel approach to multipotency. Cell Transplant. 2014; 23(12):1489–500. Epub 2013/09/21.
https://doi.org/10.3727/096368913X672037 PMID: 24044359.
5. Maioli M, Rinaldi S, Migheli R, Pigliaru G, Rocchitta G, Santaniello S, et al. Neurological morphofunc-
tional differentiation induced by REAC technology in PC12. A neuro protective model for Parkinson’s
disease. Scientific reports. 2015; 5:10439. https://doi.org/10.1038/srep10439 PMID: 25976344
6. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Gualini S, et al. Radio electric conveyed
fields directly reprogram human dermal skin fibroblasts toward cardiac, neuronal, and skeletal muscle-
Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs
PLOS ONE | https://doi.org/10.1371/journal.pone.0211188 January 23, 2019 13 / 15
like lineages. Cell Transplant. 2013; 22(7):1227–35. Epub 2012/10/13. https://doi.org/10.3727/
096368912X657297 PMID: 23057961.
7. Collodel G, Fioravanti A, Pascarelli NA, Lamboglia A, Fontani V, Maioli M, et al. Effects of regenerative
radioelectric asymmetric conveyer treatment on human normal and osteoarthritic chondrocytes
exposed to IL-1β. A biochemical and morphological study. Clinical interventions in aging. 2013; 8:309.
https://doi.org/10.2147/CIA.S42229 PMID: 23682210
8. Maioli M, Rinaldi S, Santaniello S, Castagna A, Pigliaru G, Delitala A, et al. Anti-senescence efficacy of
radio-electric asymmetric conveyer technology. Age (Dordr). 2013. Epub 2013/05/09. https://doi.org/
10.1007/s11357-013-9537-8 PMID: 23653328.
9. Rinaldi S, Maioli M, Santaniello S, Castagna A, Pigliaru G, Gualini S, et al. Regenerative treatment
using a radioelectric asymmetric conveyor as a novel tool in antiaging medicine: an in vitro beta-galacto-
sidase study. Clinical interventions in aging. 2012; 7:191. https://doi.org/10.2147/CIA.S33312 PMID:
22807628
10. Rinaldi S, Maioli M, Pigliaru G, Castagna A, Santaniello S, Basoli V, et al. Stem cell senescence. Effects
of REAC technology on telomerase-independent and telomerase-dependent pathways. Scientific
reports. 2014; 4:6373. https://doi.org/10.1038/srep06373 PMID: 25224681
11. Maioli M, Rinaldi S, Pigliaru G, Santaniello S, Basoli V, Castagna A, et al. REAC technology and hya-
luron synthase 2, an interesting network to slow down stem cell senescence. Scientific reports. 2016;
6:28682. Epub 2016/06/25. https://doi.org/10.1038/srep28682 PMID: 27339908.
12. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibro-
blast cultures by defined factors. cell. 2006; 126(4):663–76. https://doi.org/10.1016/j.cell.2006.07.024
PMID: 16904174
13. Trounson A, DeWitt ND. Pluripotent stem cells progressing to the clinic. Nature reviews Molecular cell
biology. 2016; 17(3):194–200. https://doi.org/10.1038/nrm.2016.10 PMID: 26908143.
14. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. cell. 2007; 131(5):861–72. https://doi.org/10.
1016/j.cell.2007.11.019 PMID: 18035408
15. Tohyama S, Fukuda K. Future treatment of heart failure using human iPSC-derived cardiomyocytes.
Etiology and Morphogenesis of Congenital Heart Disease: Springer; 2016. p. 25–31.
16. Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R. Cardiac differentiation of human pluripotent stem
cells in scalable suspension culture. Nature protocols. 2015; 10(9):1345–61. https://doi.org/10.1038/
nprot.2015.089 PMID: 26270394.
17. Cao N, Liu Z, Chen Z, Wang J, Chen T, Zhao X, et al. Ascorbic acid enhances the cardiac differentiation
of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell
research. 2012; 22(1):219–36. https://doi.org/10.1038/cr.2011.195 PMID: 22143566.
18. Yassa ME, Mansour IA, Sewelam NI, Hamza H, Gaafar T. The impact of growth factors on human
induced pluripotent stem cells differentiation into cardiomyocytes. Life sciences. 2018; 196:38–47.
https://doi.org/10.1016/j.lfs.2018.01.009 PMID: 29337067
19. Nsair A, MacLellan WR. Induced pluripotent stem cells for regenerative cardiovascular therapies and
biomedical discovery. Advanced drug delivery reviews. 2011; 63(4–5):324–30. https://doi.org/10.1016/
j.addr.2011.01.013 PMID: 21371511.
20. Martins AM, Vunjak-Novakovic G, Reis RL. The current status of iPS cells in cardiac research and their
potential for tissue engineering and regenerative medicine. Stem cell reviews. 2014; 10(2):177–90.
https://doi.org/10.1007/s12015-013-9487-7 PMID: 24425421.
21. Xue Y, Cai X, Wang L, Liao B, Zhang H, Shan Y, et al. Generating a non-integrating human induced plu-
ripotent stem cell bank from urine-derived cells. PloS one. 2013; 8(8):e70573. Epub 2013/08/14. https://
doi.org/10.1371/journal.pone.0070573 PMID: 23940595.
22. Cibrian-Uhalte E, Abdelilah-Seyfried S. Cell Polarity. Encyclopedic Reference of Genomics and Proteo-
mics in Molecular Medicine. Berlin, Heidelberg: Springer Berlin Heidelberg; 2006. p. 237–43.
23. Lorenzini L, Giuliani A, Sivilia S, Baldassarro VA, Fernandez M, Lotti Margotti M, et al. REAC technol-
ogy modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse
model. Sci Rep. 2016; 6:35719. Epub 2016/10/25. https://doi.org/10.1038/srep35719 PMID: 27775040
interests to declare. R.S. and F.V. are the inventors of REAC Technology.
24. Berlinguer F, Pasciu V, Succu S, Cossu I, Caggiu S, Addis D, et al. REAC technology as optimizer of
stallion spermatozoa liquid storage. Reproductive biology and endocrinology: RB&E. 2017; 15(1):11.
Epub 2017/02/10. https://doi.org/10.1186/s12958-017-0229-6 PMID: 28179013.
25. Sanna Passino E, Rocca S, Caggiu S, Columbano N, Castagna A, Fontani V, et al. REAC regenerative
treatment efficacy in experimental chondral lesions: a pilot study on ovine animal model. Clin Interv
Aging. 2017; 12:1471–9. Epub 2017/10/27. https://doi.org/10.2147/CIA.S140976 PMID: 29066871.
Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs
PLOS ONE | https://doi.org/10.1371/journal.pone.0211188 January 23, 2019 14 / 15
26. Panaro MA, Aloisi A, Nicolardi G, Lofrumento DD, De Nuccio F, La Pesa V, et al. Radio Electric Asym-
metric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration.
Neurosci Bull. 2018; 34(2):270–82. Epub 2017/11/11. https://doi.org/10.1007/s12264-017-0188-0
PMID: 29124672.
27. Rinaldi S, Meloni MA, Galleri G, Maioli M, Pigliaru G, Cugia G, et al. Radio Electric Asymmetric Con-
veyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity. PLoS
One. 2018; 13(7):e0200128. Epub 2018/07/07. https://doi.org/10.1371/journal.pone.0200128 PMID:
29979723 affiliated with the commercial organization Virostatic s.r.l., Alghero, Italy. This does not alter
our adherence to PLOS ONE policies on sharing data and materials.
28. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripo-
tent stem cells from urine samples. Nature protocols. 2012; 7(12):2080–9. Epub 2012/11/10. https://doi.
org/10.1038/nprot.2012.115 PMID: 23138349.
29. Weng Z, Kong CW, Ren L, Karakikes I, Geng L, He J, et al. A simple, cost-effective but highly efficient
system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev.
2014; 23(14):1704–16. Epub 2014/02/26. https://doi.org/10.1089/scd.2013.0509 PMID: 24564569.
30. Hernndez D, Millard R, Sivakumaran P, Wong RCB, Crombie DE, Hewitt AW, et al. Electrical Stimula-
tion Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells. Stem Cells Interna-
tional. 2016; 2016:12. https://doi.org/10.1155/2016/1718041 PMID: 26788064
31. Serena E, Figallo E, Tandon N, Cannizzaro C, Gerecht S, Elvassore N, et al. Electrical stimulation of
human embryonic stem cells: Cardiac differentiation and the generation of reactive oxygen species.
Experimental Cell Research. 2009; 315(20):3611–9. https://doi.org/10.1016/j.yexcr.2009.08.015 PMID:
19720058
32. Trollinger DR, Rivkah Isseroff R, Nuccitelli R. Calcium channel blockers inhibit galvanotaxis in human
keratinocytes. Journal of Cellular Physiology. 2002; 193(1):1–9. https://doi.org/10.1002/jcp.10144
PMID: 12209874
33. Ventura C, Maioli M, Asara Y, Santoni D, Mesirca P, Remondini D, et al. Turning on stem cell cardiogen-
esis with extremely low frequency magnetic fields. The FASEB Journal. 2005; 19(1):155–7. https://doi.
org/10.1096/fj.04-2695fje PMID: 15507470
34. Serena E, Figallo E, Tandon N, Cannizzaro C, Gerecht S, Elvassore N, et al. Electrical stimulation of
human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp
Cell Res. 2009; 315(20):3611–9. Epub 2009/09/02. https://doi.org/10.1016/j.yexcr.2009.08.015 PMID:
19720058.
35. Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM. Redox signaling in cardiac myocytes. Free
Radic Biol Med. 2011; 50(7):777–93. Epub 2011/01/18. https://doi.org/10.1016/j.freeradbiomed.2011.
01.003 PMID: 21236334.
36. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and patho-
physiology. Physiol Rev. 2007; 87(1):245–313. Epub 2007/01/24. https://doi.org/10.1152/physrev.
00044.2005 PMID: 17237347.
37. Yang Y, Mlodzik M. Wnt-Frizzled/planar cell polarity signaling: cellular orientation by facing the wind
(Wnt). Annual review of cell and developmental biology. 2015; 31:623–46. https://doi.org/10.1146/
annurev-cellbio-100814-125315 PMID: 26566118
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